![James Levine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 128 660 $ in data 31/05/2026
James E.
Levine is currently Chief Financial Officer at Kazia Therapeutics Ltd. since 2026.
Formerly, Chief Financial Officer at Cardiff Oncology, Inc. from 2021 to 2026.
Chief Financial Officer at Cidara Therapeutics, Inc. from 2018 to 2021.
President, Chief Executive & Financial Officer at Sapphire Energy, Inc. from 2014 to 2018.
President & Chief Executive Officer at Verenium Corp.
from 2013 to 2014.
Director at Biotechnology Innovation Organization from 1997 to 2000.
Chief Executive Officer & Director at Annai Systems, Inc. Managing Director-Investment Banking at Goldman Sachs & Co. LLC.
Education includes undergraduate degree from Brandeis University and MBA from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/04/2026 | 67.716 ( 0,1% ) | 128 660 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Direttore Finanziario/CFO | 01/06/2026 |
| Società | Posizione | Fine |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Direttore Finanziario/CFO | 27/01/2026 |
| CIDARA THERAPEUTICS | Direttore Finanziario/CFO | 09/07/2021 |
Sapphire Energy, Inc.
 Sapphire Energy, Inc. Oil & Gas ProductionEnergy Minerals Develops and produces algae-based crude oil | Amministratore Delegato | 30/11/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direttore/Membro del Consiglio | 01/01/2000 |
Annai Systems, Inc.
 Annai Systems, Inc. Information Technology ServicesTechnology Services Provides technological services for genomic research and medicine | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Sapphire Energy, Inc.
Sapphire Energy, Inc. Oil & Gas ProductionEnergy Minerals Develops and produces algae-based crude oil | Energy Minerals |
Annai Systems, Inc.
Annai Systems, Inc. Information Technology ServicesTechnology Services Provides technological services for genomic research and medicine | Technology Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
